How to eat on a GLP-1 (and why most people get it wrong)

By Kokei Abam, RDN · Registered Dietitian Nutritionist

Published June 2, 2026 · Last reviewed June 2, 2026 · 12 min read

A GLP-1 diet plan is a nutrition approach built specifically to address the physiological effects of semaglutide or tirzepatide. These medications delay gastric emptying, suppress appetite, and alter gastrointestinal function, so without a structured meal plan, food intake becomes too low or inconsistent to meet nutritional needs. A GLP-1 diet plan addresses that by increasing protein intake to prevent muscle loss, adjusting meal size and composition, and introducing meal timing to reduce food intolerance like nausea, bloating, and constipation. The aim is to ensure you eat adequately enough to stay on your medication and get the best results out of it.

A GLP-1 diet plan defines how to eat on semaglutide or tirzepatide to reduce food intolerance, prevent muscle loss, and sustain long-term results. This guide is written specifically for individuals actively on GLP-1 medications and is primarily informed by the 2025 joint advisory titled Nutritional Priorities to Support GLP-1 Therapy for Obesity, published by Mozaffarian et al. in The American Journal of Clinical Nutrition on behalf of four leading nutrition and obesity organizations.¹ Semaglutide and tirzepatide alter appetite signaling, slow gastric emptying, and change how the body absorbs and tolerates food, and in doing so, deplete micronutrients, accelerate muscle loss, and increase gastrointestinal intolerance in ways that require structured nutritional management. Without it, the medications work as intended but the body lacks the nutritional foundation to preserve muscle, maintain the quality of the weight loss, and sustain the results achieved during treatment.

What Is a GLP-1 Diet Plan?

A GLP-1 diet plan is not an existing dietary pattern. It is a way of eating that is shaped in response to what semaglutide and tirzepatide do to your digestion, your appetite, and your body's ability to absorb and use nutrients effectively during medication. Food composition and meal timing must be arranged around the altered impact on gastric motility, appetite signaling, and nutrient bioavailability.

How GLP-1 Medications Change the Way You Eat

Semaglutide and tirzepatide alter three mechanisms that change how you eat:

1. Delayed Gastric Emptying: Food moves from your stomach into your small intestine more slowly than before treatment, which is why you feel full faster and stay full longer. Fried foods, fatty meats, cruciferous vegetables, and large volume meals take considerably longer to digest, resulting in nausea, bloating, and constipation.
2. Reduced Appetite Signaling: These medications work on the hypothalamus, the part of your brain that regulates hunger, by extending satiety, so hunger can no longer be relied upon as a signal that your body needs food, which is why nutritional deficiencies develop.
3. Gastrointestinal Sensitivity: Slowed gastric emptying makes the gastrointestinal tract significantly more reactive to high fat meals, high fiber foods, carbonated drinks, and fried foods, triggering nausea, bloating, constipation, and sulfur burps. Sulfur burps occur when delayed gastric emptying allows high sulfur foods including eggs, red meat, garlic, and onions to ferment in the stomach, producing hydrogen sulfide gas that is expelled as burps with a distinct sulfur odor. Tirzepatide, which activates both GIP and GLP-1 receptors simultaneously, produces a more potent effect than semaglutide, making all of these symptoms more pronounced particularly during the first weeks of dose escalation.

Why Diet Matters When You're Taking a GLP-1 Medication

Diet determines the quality of weight loss, the tolerability of the medication, and the sustainability of results when treatment ends. GLP-1 medications reduce appetite and accelerate weight loss, but Hall et al. (2015) demonstrated that the body does not automatically prioritize fat as its primary fuel source under significant caloric restriction.² Glycogen, the body's immediate energy reserve stored in the liver and muscle, depletes first. As glycogen levels fall and caloric intake remains significantly reduced, the body initiates gluconeogenesis, a metabolic process where muscle tissue is broken down to access amino acids and converted to glucose to maintain brain function and red blood cell production. Without adequate dietary protein to protect muscle tissue from this process, a significant proportion of weight lost on GLP-1 therapy comes from lean mass rather than fat.

Side Effect Reduction Starts With Food

Reducing nausea, bloating, and constipation on GLP-1 therapy starts with food composition, meal volume, and timing. These symptoms are the effects of delayed gastric emptying being further laden by high fat meals, large food volumes and carbonated drinks — eating patterns that place the greatest demand on a digestive system that has already lost its normal clearing rate. Addressing this significantly reduces side effects before any pharmacological intervention becomes necessary.

The Muscle Loss Problem Nobody Talks About

Mocciaro, Capodici, and De Amicis (2025) found that between 25 and 40% of total weight lost on GLP-1 therapy comes from lean mass rather than fat when protein intake is insufficient,³ with a patient losing 20 kilograms potentially losing 5 to 8 kilograms of muscle, which slows resting metabolic rate, reduces physical strength, and makes weight maintenance significantly harder when treatment ends.

The Mozaffarian et al. advisory (2025) establishes that the standard population protein recommendation of 0.8 grams per kilogram of body weight daily does not meet the nutritional demands of patients on GLP-1 therapy, recommending 1.2 to 1.6 grams per kilogram of body weight daily with a minimum of 25 to 30 grams per meal to effectively support muscle protein synthesis. For a 90 kilogram patient, that is between 108 and 144 grams of protein daily.¹

Structured resistance training paired with adequate protein intake produces significantly better muscle retention outcomes than protein alone on GLP-1 medication. Liu et al. (2025) established that as weight reduces, mechanical load on the skeleton decreases, reducing the stimulus for bone remodeling under Wolff's Law,⁴ while prolonged caloric restriction raises deficiency risk for calcium and vitamin D, making bone density loss a predictable consequence of GLP-1 therapy, particularly in older adults and postmenopausal women.

Eating Enough to Stay on Treatment

A 2025 JAMA Network Open cohort study found that 46.5% of patients with type 2 diabetes and 64.8% without discontinued GLP-1 therapy within one year,⁵ with gastrointestinal side effects the leading non-cost reason for stopping. The appetite suppression and delayed gastric emptying that drives weight loss simultaneously reduces nutritional intake and increases food intolerance, making staying on treatment genuinely difficult without deliberate dietary management.

Interpreting the absence of hunger cues as permission to eat inconsistently leads to a cascade of side effects. Impaired gastric acid production reduces B12 absorption, raising homocysteine levels and producing the fatigue, cognitive slowing, and mood disturbance that compromises consistent eating further. This in turn reduces iron absorption, depleting Thyroid Peroxidase activity and slowing resting metabolic rate, manifesting as unexplained persistent fatigue and hair loss.

Depleted iron status impairs magnesium-dependent activation of vitamin D, leaving it functionally inactive, which prevents calcium absorption and accelerates bone density loss. This simultaneously worsens the constipation and muscle cramping patients attribute to the medication. Thiamine depletion from persistent vomiting then impairs cellular energy production through the Krebs cycle, presenting as progressive fatigue and in severe cases neurological dysfunction, compounded further by folate and choline deficiencies that affect methylation, cognitive function, and liver health that standard GLP-1 follow-up rarely screens for.

On GLP-1 therapy, hunger is no longer a reliable signal, and zinc deficiency further dulls taste perception, reducing the motivation to eat consistently. GLP-1 medications also alter dopamine-mediated food reward, producing loss of food appeal and social withdrawal around meals. This is a neurological effect of the medication, not a personal failing, and one worth raising with your provider if it affects dietary adherence or quality of life.

Core Diet Principles for GLP-1 Users

The dietary principles on a GLP-1 diet plan are a flexible framework designed to work across different stages of dosage, tailored to your individual food preferences in order to improve your tolerance of the medication.

Protein First at Every Meal

Prioritizing protein at the start of your meal is critical while taking GLP-1 medications because food clears more slowly, satiety arrives faster, and available space for intake is significantly limited. Eating protein first ensures the most critical macronutrient for muscle mass preservation is prioritized before reduced stomach capacity limits what can be consumed.

Driven by the medication's alteration of taste and food reward pathways, especially in the early weeks of titration where nausea is most profound, solid protein like meat may be difficult to consume consistently. Meat aversion is a common response on GLP-1 medication. Current clinical guidance recommends 1.2 to 1.6 grams of protein per kilogram of body weight daily,¹ with a minimum of 25 to 30 grams per meal, and if you find meat intolerable, there are other high protein options to ensure you are meeting that recommended dietary allowance, including Greek yogurt, cottage cheese, protein shakes, and tofu, all of which are generally better tolerated on a slowed digestive system.

Smaller Meals, More Often

Standard three-meal structures fail on GLP-1 therapy because slower gastric emptying causes the stomach not to adequately clear before the next meal, so smaller spaced meals are better tolerated, allowing the slowed digestive system to empty more comfortably between meals. As treatment progresses and appetite partially returns, meal volume can increase but protein remains the priority regardless of dosage stage. Three to four small meals spaced three to four hours apart, each built around a protein source of 25 to 30 grams, gives the stomach adequate clearance time while meeting daily protein targets without overwhelming a slowed digestive system.

Hydration Is a Clinical Priority

GLP-1 therapy can reduce thirst, and with nausea and smaller meals, fluid intake often drops unnoticed. This can lead to dehydration, which worsens constipation, fatigue, and nausea. Water consumed during meals adds to gastric volume in a stomach that is already clearing slowly, increasing early satiety and reducing available capacity for food.

Sipping water consistently between meals helps with hydration and better gastric movement. Aim for a minimum of 2 liters of water per day. If nausea, vomiting, or diarrhea is present, loss of sodium, potassium, and magnesium increases and are not replaced by only water; in this case, electrolyte replacement should be discussed with your physician.

Fiber — Necessary but Strategic

Fiber is necessary to manage constipation caused by slowed gastrointestinal motility, but the type of fiber and the rate of introduction influences tolerance, as certain fibers can worsen bloating and fullness. Soluble fiber like oats, soft fruits, and vegetables like carrot and broccoli dissolves in water and forms a gel in the digestive tract that supports movement without producing gas, making it the better tolerated option on a slowed digestive system. Insoluble fiber like whole grains and nuts adds bulk, ferments in your stomach causing bloating, and adds to the feeling of fullness. For this reason, fiber intake should be increased gradually, starting with soluble sources, to allow the gastrointestinal tract to adapt without worsening symptoms.

Timing matters equally because fiber consumed at the same meal as protein adds to the volume in the stomach's limited capacity, so on low-appetite days or during early titration, fiber is best eaten at a separate time to protect protein intake.

Blood Sugar Stability Through Food Pairing

When carbohydrates are eaten alone, they break down into glucose and enter the bloodstream faster. Under normal digestive conditions, the body manages this efficiently, but on GLP-1 medication delayed gastric emptying disrupts this process. When food stays longer in the stomach, glucose release becomes less predictable, and the resulting blood sugar fluctuations trigger nausea, energy crashes, and gastrointestinal sensitivity that may be attributed to the medication rather than the meal that preceded it. On tirzepatide specifically, which activates the GIP receptor alongside GLP-1 and directly influences glucose metabolism, blood sugar instability is worse than on semaglutide.

Adding protein and a small amount of fat with every carbohydrate moderates the rate at which glucose enters the bloodstream, reducing the blood sugar fluctuations that destabilize gastrointestinal tolerance. Fat slows digestion and protein reduces the glycemic response, so that carbohydrates are absorbed without triggering the reactive symptoms associated with unbalanced meals.

This is why protein-first meals are important rather than a convenient snack alone. This structure keeps blood sugar stable, gastrointestinal symptoms manageable, and energy consistent throughout the day on a medication that has made the body significantly more reactive to meal composition and timing.

Best Foods to Eat on a GLP-1 Medication

The best foods to eat on GLP-1 medications are selected by how well they function within the physiological changes the medications produce:

1. Foods That Clear a Slowed Digestive System Efficiently: Eggs, white fish, tofu, Greek yogurt, and cottage cheese are low fat, easily digestible protein sources that move through a delayed gastric emptying system without causing nausea, bloating, or gastric overload.
2. Foods That Stabilize Blood Sugar Without Gastric Overload: Oats, sweet potato, white rice, and cooked vegetables provide glucose at a rate a GLP-1-slowed digestive system can manage without triggering reactive nausea or energy crashes. Paired with protein, they support blood sugar stability without adding excessive gastric volume.
3. Foods That Support Motility Without Worsening Bloating: Cooked vegetables, soft fruits, and oats deliver soluble fiber that supports gastrointestinal motility and addresses constipation without the fermentation that raw vegetables and high insoluble fiber foods produce on a slowed digestive system.
4. Foods That Deliver Micronutrient Density in Small Volumes: Eggs, leafy greens, salmon, and fortified dairy deliver iron, B12, vitamin D, calcium, and zinc in small portions which addresses the micronutrient deficiency risk that reduced food volume on GLP-1 therapy creates without requiring large meal volumes to do so.

High-Quality Protein Sources (Muscle Preservation)

Protein is the most critical nutritional priority for muscle mass preservation on GLP-1 therapy, and not all protein sources are complete proteins. Those containing all nine essential amino acids directly stimulate the muscle protein synthesis required to protect lean mass during rapid weight loss. Collagen protein, regardless of how it is marketed, is incomplete and does not contribute to muscle preservation, so it should not be counted toward daily protein targets.

If you tolerate animal protein, chicken breast, turkey, eggs, Greek yogurt, cottage cheese, and fatty fish like salmon and tuna deliver high amino acid density in portions a slowed digestive system manages well. Meat aversion is common on GLP-1 medication, and for patients who find animal protein intolerable, eggs, Greek yogurt, cottage cheese, and whey protein isolate remain complete protein alternatives that are better tolerated. Soy and pea protein isolates are the only plant-based options that deliver a complete amino acid profile, provided daily targets of 1.2 to 1.6 grams per kilogram of body weight are consistently met.

Low-Volume, Nutrient-Dense Foods (Maximizing Limited Appetite)

When appetite suppression reduces total food volume on GLP-1 therapy, every meal must deliver maximum caloric and nutrient return in minimum volume. Avocado, nut butters, cheese, sardines, and fortified foods are energy dense and micronutrient rich, requiring small portions to meaningfully contribute to daily energy and nutritional targets. On this medication, eating foods that carry you nutritionally through the day matters more than how "clean" they are.

GI-Friendly Carbohydrates (Tolerability)

White rice, oats, sweet potato, and cooked vegetables deliver energy and digestible fiber in portions that clear a GLP-1-slowed digestive system without triggering the bloating, nausea, or early fullness that compromises protein intake.

Foods That Help Manage Nausea (Symptom Relief)

Delayed gastric emptying makes strong food aromas and heavy textures primary nausea triggers on GLP-1 therapy. Natural ginger reduces nausea by accelerating gastric emptying and inhibiting serotonin receptors in the gastrointestinal tract, peppermint tea relaxes the smooth muscle of the gastrointestinal tract reducing nausea and gastric pressure, cold or room temperature foods produce significantly less aroma than hot foods reducing olfactory-triggered nausea, and bland carbohydrates in small amounts place minimal digestive demand on a stomach that is already clearing slowly.

Hydration-Supporting Foods (Fluid and Electrolyte Balance)

GLP-1 therapy reduces thirst cues alongside appetite, and smaller meal volumes reduce incidental fluid intake from food, making dehydration a consistent and unrecognized risk. Broth-based soups, water-rich fruits like melon, cucumber, and berries, smoothies, and real fruit popsicles contribute to hydration and electrolyte balance without the gastric volume that drinking large amounts of water with meals produces.

Easy-Prep, Low-Effort Foods (Practical Adherence)

On GLP-1 therapy, fatigue and low appetite are real, and if a meal requires long preparation time, it will not get eaten. Rotisserie chicken, single-serve Greek yogurt, hard-boiled eggs, cheese, canned fish, and protein shakes keep protein accessible on the days when energy and motivation are lowest, removing the preparation barrier that causes patients to skip meals and fall short of daily protein targets.

Naturally Digestive-Supportive Foods (Gastric Motility Support)

Bitter-tasting greens such as arugula, dandelion, and endive can promote gastric acid and bile secretion, helping to support digestive motility in the context of GLP-1 therapy. Plain kefir, sauerkraut, and miso introduce live cultures that influence gut motility and intestinal function. Warm lemon water between meals provides gentle cephalic phase digestive stimulation without adding gastric volume. These are particularly relevant during later titration and maintenance phases when improving solid food tolerability and reintroducing food variety.

How to Structure Meals When Appetite Is Low

On GLP-1 therapy, hunger is no longer a reliable signal, so meal timing must be structured. Begin by setting 4-5 meal times across the day, spaced every 3-4 hours, to allow protein intake to be met in amounts the suppressed appetite and delayed gastric emptying can tolerate. Use this schedule as a flexible framework that can be adjusted as individual tolerance becomes clearer.

After each dose increase, expect a further drop in appetite for one to two weeks. During this period, shift intake toward protein shakes, Greek yogurt, smoothies, and soft foods that are more tolerable, then gradually reintroduce food variety as tolerance improves, following a progression similar to post-bariatric nutrition protocols: starting with liquids such as protein shakes, broth-based soups, and smoothies, advancing to soft foods including scrambled eggs, yogurt, mashed vegetables, and well-cooked fish, before returning to regular meals in reduced portions as the gastrointestinal tract adapts, as outlined in the 2025 guidance from the American Journal of Clinical Nutrition.¹

Temperature and texture play important roles throughout this process as cold and room temperature foods produce significantly less aroma than hot foods, reducing olfactory-triggered nausea, while soft and blended foods place considerably less mechanical demand on a stomach that is already clearing slowly. Know that intake will vary day to day, but maintaining adequate protein and nutrients remains the primary objective.

Foods to Limit or Avoid on GLP-1 Medications

1. High Fat and Fried Foods: Dietary fat is the slowest macronutrient to clear the stomach under normal digestive conditions, and on GLP-1 therapy, delayed gastric emptying slows this process further, leaving high fat and fried foods sitting in the stomach longer than before treatment, producing sustained nausea, bloating, and prolonged fullness that consistently get attributed to the medication rather than the meal that caused it.
2. Carbonated Beverages: Carbonation introduces gas into a gastrointestinal tract already clearing slowly, rapidly occupying the limited gastric volume that protein and nutrients require, producing bloating, belching, and early satiety that reduce the capacity available for nutritionally adequate food.
3. Large Meals and Standard Portion Sizes: As a result of delayed gastric emptying, the stomach cannot clear food at its previous rate, and portion sizes that were well tolerated before treatment now exceed the functional capacity of a slowed digestive system, producing gastric overload, nausea, and vomiting regardless of food composition.
4. High Sugar Foods and Drinks: Without protein or fat to moderate glucose absorption, high sugar foods produce rapid blood sugar fluctuations that a GLP-1-altered gastrointestinal tract is poorly equipped to buffer, triggering energy crashes.
5. Raw Fibrous Vegetables in Large Quantities: Insoluble fiber from raw vegetables ferments in a stomach that cannot clear it efficiently, and the significantly extended fermentation time that delayed gastric emptying produces makes large quantities of raw fibrous vegetables a primary driver of bloating, gas, and gastric discomfort on GLP-1 therapy.
6. Alcohol: Alcohol irritates the gastrointestinal lining and slows gastric motility, compounding the delayed emptying the medication already produces. Every calorie it contributes replaces protein, micronutrients, and essential nutrients in a total food volume capacity that is already significantly reduced. GLP-1 medications also reduce alcohol tolerance: delayed gastric emptying slows alcohol absorption, raising blood alcohol concentration faster and at lower quantities than before treatment, increasing intoxication faster.
7. Spicy Foods During Titration: Capsaicin, the active heat compound in spicy foods, stimulates gastrointestinal motility and increases gastric acid secretion. During titration, when the gastrointestinal tract is most sensitive to the medication's effects, this stimulation produces nausea and gastric irritation significantly more pronounced than it would outside of the titration period.

Sample Day of Eating

This is not a prescription plan. It is what a realistic day of eating on GLP-1 therapy may look like at a moderate dose of 0.5 to 1.0 mg semaglutide or equivalent tirzepatide. If you are still in early titration, do not expect to manage this structure yet because appetite suppression and gastrointestinal sensitivity are at their highest during this period, and smaller, softer, more frequent meals are the appropriate starting point before building toward this.

Hydration: Aim for a minimum of 64 ounces (8 cups) of water daily, sipped consistently between meals. Do not drink water during meals because gastric volume capacity is limited and clearing slowly. If you are experiencing dizziness or lightheadedness, water alone is not enough; add electrolytes, as these symptoms indicate sodium, potassium, or magnesium depletion that hydration alone will not correct.

7 Common Mistakes on a GLP-1 Diet Plan

GLP-1 therapy reduces total food volume, slows gastric emptying, and suppresses appetite simultaneously, leaving the body with significantly less nutritional intake to work with and significantly less digestive capacity to process it. An inadequate meal composition or a missed meal carries nutritional consequences that the same mistake would not produce off the medication.

1. Not Eating Because You Are Not Hungry

GLP-1-induced appetite suppression eliminates hunger. Waiting for hunger on this medication accelerates muscle loss, micronutrient deficiencies, and fatigue, so eating must operate on a schedule, not on reliance on appetite cue.

2. Treating All Proteins as Equal

Collagen protein, low-protein bars, and many protein snacks do not contain the complete amino acid profile required to stimulate muscle protein synthesis. Only complete proteins like eggs, Greek yogurt, chicken, fish, whey, soy, and pea isolates protect lean mass during rapid weight loss.

3. Eating the Same Portions as Before Medication

Delayed gastric emptying significantly reduces functional stomach capacity, so portions that were well tolerated before treatment now exceed what a slowed digestive system can clear, producing nausea, bloating, and vomiting that patients attribute to the medication rather than meal volume. Smaller, more frequent meals resolve this issue effectively.

4. Avoiding All Fat Because It Causes Nausea

High fat meals worsen nausea on GLP-1 therapy, but eliminating fat entirely removes the caloric and nutrient density the body requires when total food volume is significantly reduced. Small amounts of healthy fat from avocado, eggs, fatty fish, and nut butters support nutrient absorption and sustained energy without the gastric overload that large fat portions cause.

5. Loading Up on Fiber to Fix Constipation

Insoluble fiber from raw vegetables, whole grains, and bran ferments in a stomach that is already clearing slowly, worsening the bloating and discomfort it is intended to resolve, while soluble fiber from oats, cooked vegetables, and soft fruits supports motility without fermentation. Fiber intake should be increased gradually and timed away from primary protein meals to protect gastric capacity.

6. Drinking Calories Without Protein

Fruit juices, smoothies without protein, and sugary drinks deliver calories and glucose without the protein required to protect lean mass or the fat and fiber required to moderate blood sugar absorption. On a medication that has already reduced gastric capacity, liquid calories that contribute nothing toward the daily protein target of 1.2 to 1.6 grams per kilogram of body weight occupy the limited space the body most critically needs for nutritionally adequate food.

7. Not Adjusting Diet When Dose Changes

Each dose increase on GLP-1 therapy suppresses appetite further and increases gastrointestinal sensitivity for one to two weeks. Continuing the same dietary approach through a dose change causes nausea and inadequate intake, which may lead to treatment discontinuation. Moving temporarily to softer, lower-volume, easily digestible foods during dose escalation and rebuilding meal variety improves tolerability.

Do Diet Needs Differ Between GLP-1 Medications?

Semaglutide and tirzepatide share the same core dietary requirements: protein prioritization, smaller meals, consistent hydration, and symptom-based food selection apply to both. The clinical difference lies in the degree of gastrointestinal sensitivity each produces.

Tirzepatide activates both GLP-1 and GIP receptors, producing a broader physiological effect than semaglutide's single receptor action. Xie et al. (2025), in a Bayesian network meta-analysis of 48 randomized controlled trials involving 27,729 participants published in Frontiers in Pharmacology, found that tirzepatide carried the highest overall risk of nausea and diarrhea across all GLP-1 receptor agonists, while semaglutide, though lower risk than tirzepatide, demonstrated a significantly higher risk of diarrhea specifically when compared to other single receptor GLP-1 agents in the class.⁶

Frequently Asked Questions

What exactly is a GLP-1 diet plan and is it different from a regular weight loss diet?

Unlike a standard weight loss diet, which operates on the premise of reducing calories, GLP-1 medications already handle this by slowing gastric emptying and suppressing appetite at a neurological level. A GLP-1 diet plan is a direct response to those changes, making sure that the effects of this medication do not cause inadequate eating that results in muscle loss and nutrient deficiency, and that the weight loss it produces remains sustainable long term.

What should I eat on Ozempic to get the best results?

The foods to get the best results on Ozempic are those that prioritize muscle preservation through complete proteins like eggs, chicken, Greek yogurt, and fish; stabilize blood sugar and move efficiently through a slowed digestive system like white rice, oats, cooked vegetables, and soft fruits; reduce nausea and vomiting like natural ginger, cold and room temperature meals; deliver energy and nutrient density even in small quantities like avocado, cottage cheese and fortified foods; and are consumed in small, well-spaced meals throughout the day.

What foods should I completely avoid on semaglutide?

On semaglutide, avoid foods that strain an already slowed digestive system, trigger gastrointestinal discomfort, spike blood sugar, or occupy the limited gastric capacity the medication creates. This includes high fat and fried foods, carbonated beverages, sugary foods and drinks, raw fibrous vegetables, spicy foods, and alcohol, all of which worsen nausea, bloating, constipation, and early satiety that are already driven by semaglutide's effect on gastric emptying.

How much protein do I actually need on a GLP-1 medication?

According to the American Journal of Clinical Nutrition, patients on GLP-1 therapy require 1.2 to 1.6 grams of protein per kilogram of body weight daily, with a minimum of 25 to 30 grams per meal to effectively support muscle protein synthesis.

Why do some foods that never bothered me before make me sick on Mounjaro?

Mounjaro slows gastric emptying, meaning food sits in your stomach significantly longer than it did before treatment. Large portions, fried foods, high fat meals and raw vegetables your digestive system previously cleared efficiently now place greater demand on your digestive system that has lost its normal clearing rate, causing nausea, bloating, and discomfort that did not exist before starting the medication.

Can I eat carbohydrates on a GLP-1 diet or do I need to cut them out?

Yes, you can eat carbohydrates but in small quantities prioritizing low glycemic options like oats, sweet potato, white rice, and cooked vegetables, and must be paired with protein and fat to moderate glucose absorption and keep blood sugar stable throughout the day. Eaten alone, carbohydrates can cause rapid blood sugar fluctuations that trigger reactive nausea and energy crashes.

I am barely eating anything on my GLP-1 medication, is that a problem?

Yes, and this is an effect of GLP-1 medication. One of its mechanisms is appetite suppression, but consistently eating too little will accelerate muscle loss, deplete micronutrient stores, trigger hair loss, slow resting metabolic rate, and may drive you off treatment prematurely without reaching your goals. Structure your meals four to five times a day, protein first, and keep it manageable with easy options like protein shakes. If this persists, have a discussion with your physician.

← All articles